Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000859

Drug Information
SynonymsHSDB 5184; Ethanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-; Doxylaminum [INN-Latin]; KBio3_001158; Doxylaminum; NCGC00089789-04; 469-21-6; Phenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether; CID3162; D004319; Prestwick1_000027; N,N-dimethyl-2-[(1-phenyl-1-pyridin-2-ylethyl)oxy]ethanamine; Pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)-; SPBio_000130; DB00366; NINDS_000841; NCGC00089789-05; BSPBio_000093; Dossilamina [DCIT]; NCGC00089789-02; Prestwick3_000027; CHEBI:51380; MolPort-005-935-542; Prestwick2_000027; C17H22N2O; NCI C60684; KBio1_000841; KBioSS_001494; Spectrum5_000949; DivK1c_000841; AC-15949; Pyridine, 2-[.alpha.-[2-(dimethylamino)ethoxy]-.alpha.-methylbenzyl]-; EINECS 207-414-2; Spectrum_001014; BRD-A44008656-036-05-0; STL018676; 2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine; AB00053466; Doxylamine [INN:BAN]; UNII-95QB77JKPL; L001076; BPBio1_000103; KBio2_006630; 2-Dimethylaminoethoxyphenylmethyl-2-picoline; SPBio_002014; KBioGR_001135; AC1L1FB8; IDI1_000841; Doxilminio; 5-21-03-00508 (Beilstein Handbook Reference); Prestwick0_000027; N,N-dimethyl-2-[1-phenyl-1-(pyridin-2-yl)ethoxy]ethanamine; Spectrum2_000115; Doxylamine (INN); Dossilamina; D07878; doxylamine; KBio2_001494; Doxilminio [INN-Spanish]; CHEMBL1004; doxilamina; Ethanamine, N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]-; KBio2_004062; N,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanamine; Spectrum4_000528; BRN 0230379; N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine; BSPBio_001938; NCGC00021147-08; Spectrum3_000409; LS-127; Lopac0_000348    
Trade NameDolased; Syndol; Mersyndol; Somnil; Dozile; Donormyl; Dormidina; Restavit; Unisom-2; Evanorm; Diclectin    
CompanyIon Healthcare    
IndicationAnxiety and morning sicknessApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassHypnotics and Sedatives    
CAS NumberCAS 469-21-6
PubChem Compound IDCID 3162.    
PubChem Substance IDSID 153331.    
SuperDrug ATC IDN05CM21;    
SuperDrug CAS ID000469216;    
TargetHistamine H1 receptorAntagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 040167 To Reference
Ref 2First-generation H1 antihistamines found in pilot fatalities of civil aviation accidents, 1990-2005. Aviat Space Environ Med. 2007 May;78(5):514-22. To Reference
Ref 3Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding. Pharmacology. 2004 Oct;72(2):92-8. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543